| Cvs Pharmacy #04536 | |
| 301 American Ave, Booneville, Mississippi 38829 | |
| (662) 720-1707 |
| Name | Cvs Pharmacy #04536 |
|---|---|
| Organization Name | Mississippi Cvs Pharmacy Llc |
| Location | 301 American Ave, Booneville, Mississippi 38829 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (662) 720-1707 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache.
NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.
Inflammatory breast cancer is a rare and little-known form of breast cancer that produces no lumps and can not usually be detected with a mammogram. Experts say thousands of women develop it each year, but unfortunately, many of them miss the early symptoms.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
› Verified 6 days ago
| NPI Number | 1255647541 |
| Organization Name | MISSISSIPPI CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY #04536 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 301 American Ave, Booneville, MS 38829 |
| Phone Number | 662-720-1707 |
News Archive
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache.
NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.
Inflammatory breast cancer is a rare and little-known form of breast cancer that produces no lumps and can not usually be detected with a mammogram. Experts say thousands of women develop it each year, but unfortunately, many of them miss the early symptoms.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
› Verified 6 days ago
News Archive
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 (Staccato(R) loxapine) in patients with migraine headache.
NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.
Inflammatory breast cancer is a rare and little-known form of breast cancer that produces no lumps and can not usually be detected with a mammogram. Experts say thousands of women develop it each year, but unfortunately, many of them miss the early symptoms.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
› Verified 6 days ago
Booneville Community Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 206 N 2nd St, Booneville, Mississippi 38829 Phone: (662) 728-1951 | |
Craig W Cleveland Od Type: Medicare Supplier Location: 202n 2nd St, Booneville, Mississippi 38829 Phone: (662) 728-6191 | |
Hill Family Eye Center Inc Type: Medicare Supplier Location: 108 South Main Street, Booneville, Mississippi 38829 Phone: (662) 720-1910 | |
Cvs Pharmacy #04536 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 301 American Ave, Booneville, Mississippi 38829 Phone: (662) 720-1707 | |
Smith Drug & Home Medical Inc Type: Community/Retail Pharmacy Location: 100 S Second St, Booneville, Mississippi 38829 Phone: (662) 728-5322 |